VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $663 | +86.2% | 22,177 | +101.7% | 0.02% | -5.6% |
| Q1 2023 | $356 | +12.7% | 10,993 | -0.4% | 0.02% | +5.9% |
| Q4 2022 | $316 | -99.9% | 11,042 | -3.0% | 0.02% | 0.0% |
| Q3 2022 | $275,000 | -11.9% | 11,389 | +0.0% | 0.02% | 0.0% |
| Q2 2022 | $312,000 | -26.2% | 11,386 | +3.2% | 0.02% | -22.7% |
| Q1 2022 | $423,000 | +22.6% | 11,037 | +2.5% | 0.02% | +29.4% |
| Q4 2021 | $345,000 | -1.4% | 10,767 | -9.4% | 0.02% | -19.0% |
| Q3 2021 | $350,000 | -21.2% | 11,882 | -9.0% | 0.02% | -22.2% |
| Q2 2021 | $444,000 | +4.0% | 13,054 | -0.7% | 0.03% | -15.6% |
| Q1 2021 | $427,000 | +112.4% | 13,147 | +135.6% | 0.03% | +88.2% |
| Q4 2020 | $201,000 | – | 5,580 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |